CFDX

Cognimark

This company develops AI software for healthcare providers to identify early signs of cognitive decline and dementia using existing electronic health records.

Optina Dx

The company develops an artificial intelligence platform and retinal imaging camera for the non-invasive detection of Alzheimer's disease and other systemic conditions for healthcare providers.

Cytox

This company develops non-invasive genetic tests for Alzheimer's disease risk assessment and patient stratification for clinicians and pharmaceutical researchers.

Punto Health

This company develops artificial intelligence tools for early dementia detection and cognitive care management for patients, carers, and healthcare providers.

Virtual memory clinic

This digital health platform provides screening, diagnosis and care management services for patients with dementia and cognitive decline.

Combinostics

This company develops AI software for quantifying brain images and patient data to support clinicians in diagnosing and managing neurological disorders.

BrainQuant

This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.

GLX Analytix

This company develops blood-based diagnostic and monitoring tests for clinicians to manage neurodegenerative, autoimmune and neuropsychiatric diseases using glycocalyx biomarkers and artificial intelligence.